344 Participants Needed

Electronic Symptom Management for Advanced Cancer

Recruiting at 7 trial locations
SE
SG
SM
Overseen BySara M Garrett, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Milton S. Hershey Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This trial is testing Nurse AMIE 3.0, a tablet-based program, to help stage 3 and 4 cancer patients in rural areas manage their symptoms. The program aims to provide remote support to improve their overall survival.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your current treatments, as the trial focuses on managing symptoms electronically.

What data supports the effectiveness of the treatment Nurse AMIE for advanced cancer?

Research shows that nurse practitioners, when involved in supportive interventions like home visits, can significantly improve pain control and quality of life for patients with advanced cancer. This suggests that treatments involving nurse-led care, like Nurse AMIE, may be effective in managing symptoms and improving patient outcomes.12345

How is the Nurse AMIE treatment different from other treatments for advanced cancer?

Nurse AMIE is unique because it uses electronic systems to help manage symptoms in real-time for people with advanced cancer, allowing patients to report symptoms as they happen and receive timely interventions, which is especially useful for those in remote areas.678910

Research Team

KS

Kathryn Schmitz, PhD

Principal Investigator

University of Pittsburgh / UPMC

Eligibility Criteria

This trial is for adults with advanced stage 3 or 4 cancer, living in certain rural areas, who are undergoing treatment (not just palliative care). They must have a life expectancy of at least 6 months, be able to use a phone for check-ins, and not be part of other supportive care studies.

Inclusion Criteria

Clinician-defined life expectancy of 6 months or more
I am currently receiving treatment for my cancer.
My cancer is stage 3, 4, or considered advanced by my doctor.
See 6 more

Exclusion Criteria

Patients who are participating in any other supportive care or behavioral intervention studies
Non-English speaking patients will be excluded, as they represent less than 2% of the population targeted.
Patients with medical or psychiatric conditions documented in the medical record (beyond cancer, its treatments, and its symptoms) that would impair our ability to test study hypotheses (e.g. psychotic disorders, dementia, inability to give informed consent, or follow study instructions)

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Measurements

Participants complete baseline measurements after informed consent

1-2 weeks

Treatment

Participants are randomly assigned to receive either the Nurse AMIE program or a supportive care book

2 years
Daily symptom assessment for Nurse AMIE group

Follow-up

Participants are monitored for survival and other outcomes after treatment

2 years

Treatment Details

Interventions

  • Nurse AMIE
  • Usual Care
Trial Overview Nurse AMIE is an electronic system designed to help manage symptoms in cancer patients. The study compares its effectiveness on survival rates against usual care without this technology among those living in rural settings.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Nurse AMIE Supportive Care InterventionExperimental Treatment1 Intervention
Participants in the intervention arm will receive the computer tablet with the Nurse AMIE program. Nurse AMIE will assess their symptoms daily and provide an intervention to help manage their symptoms.
Group II: Usual CareActive Control1 Intervention
Participants in the usual care arm will receive a book with some supportive care educational materials and recommendations.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Milton S. Hershey Medical Center

Lead Sponsor

Trials
515
Recruited
2,873,000+

University of Pittsburgh

Lead Sponsor

Trials
1,820
Recruited
16,360,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

West Virginia University

Collaborator

Trials
192
Recruited
64,700+

Mount Nittany Medical Center

Collaborator

Trials
2
Recruited
1,400+

Penn State University

Collaborator

Trials
380
Recruited
131,000+

Findings from Research

Nurse practitioners are crucial in managing breast cancer, particularly in prevention, early detection, and treatment, emphasizing the importance of health assessments as part of their core competencies.
The review of five case studies shows that eribulin mesylate can be an effective treatment option for women with metastatic breast cancer who have previously undergone at least two chemotherapy regimens, highlighting its role in managing adverse events and improving therapeutic outcomes.
Oncology nursing support for safe and effective use of eribulin in metastatic breast cancer.Donovan, D., Urquhart, L., Hopkins, U., et al.[2021]
In a study of 29 nurses involved in cancer care at a tertiary hospital in Barcelona, 31% were identified as advanced practice nurses (APNs) meeting all competency standards, highlighting the presence of skilled professionals in oncology.
Most of the identified APNs had advanced degrees, with 24.1% holding a master's degree and 6.9% holding a PhD, emphasizing the need for recognizing and utilizing their competencies to improve patient care and optimize health resources in cancer treatment.
Professional competencies of oncology nurses: Recognizing advanced practice in nursing.Muñoz-Villaverde, S., Martínez-García, M., Serrano-Oviedo, L., et al.[2023]
The advanced breast cancer clinical nurse (ABCCN) is designed to play a vital role in coordinating patient care and managing healthcare resources, ensuring that patients receive comprehensive support throughout their treatment journey.
The proposed curriculum for the ABCCN emphasizes clinical and psychosocial skills, conflict resolution, and teamwork, which are essential for optimizing patient care and resource utilization in advanced breast cancer management.
Advanced breast cancer clinical nursing curriculum: review and recommendations.Vila, C., Reñones, C., Ferro, T., et al.[2018]

References

Oncology nursing support for safe and effective use of eribulin in metastatic breast cancer. [2021]
Professional competencies of oncology nurses: Recognizing advanced practice in nursing. [2023]
Advanced breast cancer clinical nursing curriculum: review and recommendations. [2018]
Prediction and management of pain in patients with advanced cancer. [2019]
Improving End-of-Life Care Prognostic Discussions: Role of Advanced Practice Nurses. [2016]
Perceptions of the use of a remote monitoring system in patients receiving palliative care at home. [2017]
Web and mobile-based symptom management interventions for physical symptoms of people with advanced cancer: A systematic review and meta-analysis. [2021]
Real-time symptom management in the context of a remote symptom-monitoring system: prospective process evaluation and cross-sectional survey to explore clinical relevance. [2021]
Quality of telephone nursing services for adults with cancer and related non-emergent visits to the emergency department. [2020]
10.United Statespubmed.ncbi.nlm.nih.gov
Palliative care at the end of life. [2019]